Business Description
Singular Genomics Systems Inc
NAICS : 334516
SIC : 3841
ISIN : US82933R1005
Description
Singular Genomics Systems Inc is a life science technology company that is leveraging novel next generation sequencing and multiomics technologies to build products that empower researchers and clinicians. The product development pipeline comprises two initial integrated solutions, each designed to leverage Sequencing Engine and purpose built to address different applications. The G4 Sequencing Platform is designed to target the NGS market. The PX Integrated Solution is designed to target the single cell, spatial analysis and proteomics markets. Both integrated solutions are used in many different and diverse market segments, including basic biology, oncology, immunology, neurology, genetic diseases, infectious diseases, the human microbiome and many others.
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.86 | |||||
Equity-to-Asset | 0.63 | |||||
Debt-to-Equity | 0.52 | |||||
Debt-to-EBITDA | -0.86 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -2.96 | |||||
Beneish M-Score | -2.83 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -45.8 | |||||
3-Year EPS without NRI Growth Rate | -48.1 | |||||
3-Year FCF Growth Rate | -39.4 | |||||
Future 3-5Y Total Revenue Growth Rate | 89.87 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 34.16 | |||||
9-Day RSI | 33.15 | |||||
14-Day RSI | 34.86 | |||||
6-1 Month Momentum % | -50.91 | |||||
12-1 Month Momentum % | -43.34 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 8.77 | |||||
Quick Ratio | 8.04 | |||||
Cash Ratio | 7.86 | |||||
Days Inventory | 1270.88 | |||||
Days Sales Outstanding | 42.19 | |||||
Days Payable | 199.61 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -2.8 | |||||
Shareholder Yield % | -99.12 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | -41.11 | |||||
Operating Margin % | -3654.37 | |||||
Net Margin % | -3375.72 | |||||
FCF Margin % | -2864.95 | |||||
ROE % | -51.57 | |||||
ROA % | -35.53 | |||||
ROIC % | -117.3 | |||||
ROC (Joel Greenblatt) % | -119.83 | |||||
ROCE % | -37.43 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 5.73 | |||||
PB Ratio | 0.11 | |||||
Price-to-Tangible-Book | 0.11 | |||||
EV-to-EBIT | 0.5 | |||||
EV-to-Forward-EBIT | -0.04 | |||||
EV-to-EBITDA | 0.54 | |||||
EV-to-Forward-EBITDA | -0.05 | |||||
EV-to-Revenue | -16.75 | |||||
EV-to-Forward-Revenue | 0.38 | |||||
EV-to-FCF | 0.58 | |||||
Price-to-Net-Current-Asset-Value | 0.24 | |||||
Price-to-Net-Cash | 0.31 | |||||
Earnings Yield (Greenblatt) % | 200 | |||||
FCF Yield % | -492.88 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:OMIC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Singular Genomics Systems Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 2.722 | ||
EPS (TTM) ($) | -37.37 | ||
Beta | 1.37 | ||
Volatility % | 63.66 | ||
14-Day RSI | 34.86 | ||
14-Day ATR ($) | 0.548764 | ||
20-Day SMA ($) | 7.182165 | ||
12-1 Month Momentum % | -43.34 | ||
52-Week Range ($) | 5.77 - 19.8 | ||
Shares Outstanding (Mil) | 2.5 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Singular Genomics Systems Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Singular Genomics Systems Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Singular Genomics Systems Inc Frequently Asked Questions
What is Singular Genomics Systems Inc(OMIC)'s stock price today?
The current price of OMIC is $6.34. The 52 week high of OMIC is $19.80 and 52 week low is $5.77.
When is next earnings date of Singular Genomics Systems Inc(OMIC)?
The next earnings date of Singular Genomics Systems Inc(OMIC) is 2024-11-14 Est..
Does Singular Genomics Systems Inc(OMIC) pay dividends? If so, how much?
Singular Genomics Systems Inc(OMIC) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |